Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: Eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds

Neurochemistry International

Volumn 29, Issue 5, 1996, Pages 529-542

  Nankai, Masahiro ^a,b   Klarica, Marijan ^a,c   Fage, Dominique ^a   Carter, Christopher ^a  

^a Neurochemistry group   (France)

^b Tokyo Keisatsu Hospital   (Japan)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; DESIPRAMINE; DEXTROMETHORPHAN; DEXTRORPHAN; DIZOCILPINE; DOPAMINE; ELIPRODIL; GLUTAMIC ACID; GLYCINE; IFENPRODIL; MAGNESIUM; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SPERMIDINE; SPIDER VENOM;

4 AMINOBUTYRIC ACID RELEASE; ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; HIPPOCAMPUS; MEDULLA OBLONGATA; MESENCEPHALON; NEUROMODULATION; NEWBORN; NONHUMAN; PONS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; THALAMUS;

ANIMALIA; ARANEAE;

EID: 0030297929     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-0186(96)00010-1     Document Type: Article

References (70)

1. 2+ channels in rat cultured cortical neurones. Eur. J. Pharmacol. 257, 297-301.
2. Bristow I. J., Hutson P. H., Thorn L. and Tricklebank M. D. (1993) The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br. J. Pharmacol. 108, 1156-1163.
3. Carter C., Benavides J., Dana C., Schoemaker H., Perrault G., Sanger D. and Scatton B. (1991) In Excitatory Amino Acid Antagonists (B. D. Meldrum, ed.), pp. 130-163. Blackwell Scientific Publications, Oxford.
4. Carter C., Rivy J. P. and Scatton B. (1989). Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor. Eur. J. Pharmacol. 164, 611-612.
5. Carter, C. J., L'Heureux R. and Scatton B. (1988). differential control by N-methyl-D-aspartate and kinate of striatal dopamine release (dialysis) in vivo: a transstriatal dialysis study. J. Neurochem. 51, 462-468.
6. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions. Br. J. Pharmacol. 113, 499-507.
7. Coderre T. J. and Van Empel I. (1994) The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 59, 345-352.
8. Cosentino M., De Ponti F., Marino F., Giaroni C., Leoni O., Lecchini S. and Frigo G. (1995) N-methyl-D-aspartate receptors modulate neurotransmitter release and peristalsis in the guinea-pig isolated colon. Neurosci. Lett. 183, 139-142.
9. Cudennec A., Duverger D., Benavides J., Scatton B. and Nowicki J. P. (1994) Effect of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat in the rat brain. Brain Res. 664, 41-48.
10. DeSarro G. B. and DeSarro A. (1993) Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene. Neuropharmacology 32, 1-58.
11. Durand G. M., Bennett M. V. and Zukin R. S. (1993) Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proc. Natl Acad. Sci. U.S.A. 90, 6731-6735. (published erratum appears in Proc. Natl Acad. Sci. U.S.A. 90(20), 9739.)
12. Durand G. M., Gregor P., Zheng X., Bennett M. V. L., Uhl G. R. and Zuking S. (1992) Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc. Natl Acad. Sci. 89, 9359-9363.
13. Duval D., Roome N., Gauffeny C., Nowicki J. P. and Scatton B. (1992) SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons. Neurosci. Lett. 137, 193-197.
14. Ebert B., Wong E. H. F. and Krogsgaard-Larsen P. (1991) Identification of a novel NMDA receptor in rat cerebellum. Eur. J. Pharmacol. 208, 49-52.
15. 3H]MK801 binding in hippocampal synaptic membranes. Neurosci. Res. 16, 217-224.
16. Fage D., Voltz C., Scatton B. and Carter C. (1992) Selective release of spermine and spermidine from the rat striatum by N-methyl-D-aspartate receptor activation in vivo. J. Neurochem 58, 2170-2175.
17. 3H]-dextrorphan binding in rat brain is localized to a non-competitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Molec. Pharmacol. 41, 134-146.
18. Galli T., Desce J. M., Artaud F., Kernel M. L., Cheramy A. and Glowinski I. (1992) Modulation of GABA release by α-amino-3-hydroxy-5-methylisoxazole-4-propionate and N-methyl-D-aspartate receptors in matrix-enriched areas of rat striatum. Neuroscience 50, 769-780.
19. 3H]GABA from granule cell dendrites of rat olfactory bulb. J. Neurochem. 64, 662-669.
20. Gotti B., Benavides J., MacKenzie E. T. and Scatton B. (1990) The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res. 522, 290-307.
21. Hoehn K., Craig C. G. and White T. D. (1990) A comparison of N-methyl-D-aspartate-evoked release of adenosine and [3H]norepinephrine from rat cortical slices. J. Pharm. Exp. Ther. 255, 174-181.
22. Hollmann M., Boulter J., Maron C., Beasley L., Pecht C. and Heinemann S. (1993) Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron 10, 943-954.
23. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadatoni H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M. and Nakanishi S. (1993) Molecular characterisation of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268, 2836-2843.
24. Koek W. and Colpaert F. C. (1991) Use of a conflict procedure in pigeons to characterize anxiolytic drug activity: evaluation of N-methyl-D-aspartate antagonists. Life Sci. 49, 37-42.
25. Koltchine V., Anantharam V., Wilson A., Bayley H., Treistman S. N. (1993) Homomeric assemblies of NMDAR1 splice variants are sensitive to ethanol. Neurosci. Lett. 152, 13-16.
26. Kusiak J. W. and Norton D. D. (1993) A splice variant of the N-methyl-D-aspartate (NMDAR1) receptor. Molec. Brain Res. 20, 64-70.
27. Landwehrmeyer G. B., Standaert G., Testa C. M., Penney J. B. and Young A. B. (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15(7), 5297-5307.
28. Laurie D. J. and Seeburg P. H. (1994a) Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 14, 3180-3194.
29. Laurie D. J. and Seeburg P. H. (1994b) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268, 335-345.
30. Legendre P. and Westbrook G. L. (1991) Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Molec. Pharmacol. 40, 289-298.
31. Luque J. M., Bleuel Z., Malherbe P. and Richards J. G. (1994) Alternatively spliced isoforms of the N-methyl-D-aspartate receptor subunit 1 are differentially distributed within the rat spinal cord. Neuroscience 63, 629-635.
32. 3H]Dizocilpine association kinetics distinguish stimulatory and inhibitory polyamine sites of N-methyl-D-aspartate receptors. J. Neurochem. 63, 963-971.
33. Millan M. J. and Seguin L. (1994) Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice. Neurosci. Lett. 178, 139-143.
34. Monyer H., Burnashev N., Laurie D. I., Sakmann B. and Seeburg P. H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529-540.
35. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakman B. and Seeburg P. H. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217-1221.
36. Moriyoshi K., Masu M., Ishii T., Shigemeto R., Mizuno N. and Nakanishi S. (1991). Molecular cloning and characterisation of the rat NMDA receptor. Nature 354, 31-37.
37. Nakanishi N., Axel R. and Shneider N. A. (1992) Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors. Proc. Natl Acad. Sci. 89, 8552-8556.
38. Nakanishi S., Masu M., Bessho Y., Nakajima Y., Hayashi Y. and Shigemoto R. (1994) Molecular diversity of glutamate receptors and their physiological functions. FEBS Letts. 71, 71-80.
39. Nankai M., Page D. and Carter C. (1995a) NMDA receptor subtype selectivity: eliprodil, polyamine spider toxins, dextromethorphan, and desipramine selectively block NMDA-evoked striatal acetylcholine but not spermidine release. J. Neurochem. 64, 2043-2048.
40. Nankai M., Fage D. and Carter C. (1995b) Striatal NMDA receptor subtypes: the pharmacology of NMDA-evoked dopamine, γ-aminobutyric acid, acetylcholine and spermidine release. Eur. J. Pharmacol. 286, 61-70.
41. Netzer R., Pflimlin P. and Trube G. (1993) Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur. J. Pharmacol. 238, 209-216.
42. 3H]ifenprodil sites in the rat brain: possible relationship to NMDAR2B receptors and calmodulin. J. Neurochem. 63, 2248-2258.
43. 3H]spermidine from rat striatal slices in vitro. J. Neurochem. 62, 1835-1839.
44. Parsons C. G., Gruner R., Rozental J., Millar J. and Lodge D. (1993) Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32, 1337-1350.
45. Patat A., Molinier P., Hergueta T., Brohier S., Zieleniuk I., Danjou P., Warot D. and Puech A. (1994) Lack of amnesic, psychotomimetic or impairing effect of psychomotor performance of eliprodil, a new NMDA antagonist. Int. Clin. Psychopharmacol. 9, 155-162.
46. 2+], sensitive dye INDO-1. Neuropharmacology 34, 35-42.
47. Porter R. H. P. and Greenamyre J. T. (1995) Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J. Neurochem. 64, 614-623.
48. Priestley T., Ochu E. and Kemp J. A. (1994) Subtypes of NMDA receptor in neurones cultured from rat brain. Neuroreport 5, 1763-1765.
49. 636. FEBS Letts. 324, 63-66.
50. Reynolds I. J. and Miller R. J. (1989) Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. Molec. Pharmacol. 36, 758-765.
51. 3H]MK801 binding to rat brain N-Methyl-D-aspartate receptors. J. Neurochem. 56, 1731-1740.
52. Rothman S. (1988) Noncompetitive N-methyl-D-aspartate antagonists affect multiple ionic currents. J. Pharm. Exp. Ther. 246, 137-142.
53. 3H]arachidonate in hippocampal slices of immature rats. Acta Neurobiol. Exp. 55, 11-21.
54. Sanger D. J. and Joly D. (1991) Effects of NMDA receptor antagonists and sigma ligands on the acquisition of conditioned fear in mice. Psychopharmacology 104, 27-34.
55. 3H-acetylcholine release evoked by excitatory amino acids. Nature 297, 422-424.
56. Schwarz M., Block F. and Sontag K. H. (1992) N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of memantine in rats. Neurosci. Lett. 143, 105-109.
57. Sugihara H., Moriyoshi K., Ishii T., Masu M. and Nakanishi S. (1992) Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem. Biophys. Res. Comm. 268, 826-832.
58. Tolle T. R., Berthele A., Zieglgansberger W., Seeburg P. H. and Wisden W. (1993) The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci. 13, 5009-5028.
59. Toulmond S., Serrano A., Benavides J. and Scatton B. (1993) Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window. Brain Res. 620, 32-41.
60. Tricklebank M. D., Bristow I. J. and Hutson P. H. (1992) Alternative approaches to the discovery of novel anti-psychotic agents. Prog. Drug Res. 38, 299-336.
61. Tricklebank M. D., Singh L., Oles R. J., Preston C. and Iversen S. D. (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167, 127-135.
62. Trullas R. and Skolnick P. (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 185, 1-10.
63. Watanabe M., Inoue Y., Sakimura K. and Mishina M. (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3, 1138-1140.
64. Watanabe M., Inoue Y., Sakimura K. and Mishina M. (1993) Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain. J. Comp. Neurol. 338, 377-390.
65. Williams K. (1993) Ifenprodil discriminates subtype of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Molec. Pharmacol. 44, 851-859.
66. Williams K. (1995) Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the E4 (NR2D) subunit. Neurosci. Letts 184, 181-184.
67. Williams K., Russell S. L., Shen Y. M. and Molinoff P. B. (1993) Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10, 267-278.
68. Williams K., Zappia A. M., Pritchett D. B., Shen Y. M. and Molinoff P. B. (1994) Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Molec. Pharmacol. 45, 803-809.
69. Yoneda Y. and Ogita K. (1991) Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques. J. Pharmacol. Exp. Ther. 259, 86-96.
70. Zhong J., Carrozza D. P., Williams K., Pritchett D. B. and Molinoff P. B. (1995). Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J. Neurochem. 64, 531-539.